Endoscopic sleeve gastroplasty versus lifestyle modifications for class II obesity patients: a French cost-effectiveness analysis.

Date publication

janvier 2025

Journal

Surgical endoscopy

Auteurs

Membres identifiés du Cancéropôle Est :
Pr MUTTER Didier

Tous les auteurs :
Vannucci M, Riva P, Vix M, Mutter D, Keller DS, Perretta S

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/39789230

Résumé

Obesity is a worldwide epidemic, with up to 17% of French population affected. European guidelines recommend surgical management at specific weight and comorbidity level; however, less than 2% of eligible patients undergo surgical bariatric interventions. To extend the benefits of bariatric interventions to the untreated population with obesity, endoscopic techniques such as endoscopic sleeve gastroplasty (ESG) have been developed. Analysis of costs and long-term benefits of ESG across stakeholders is needed. This work aimed to assess the healthcare economic and outcomes for ESG in the French healthcare system.

Mots clés

Bariatric intervention, Cost-effectiveness model, Interventional endoscopy, Obesity

Référence

Surg Endosc. 2025 01 9;: